Keudell/Morrison Wealth Management
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1785498
Salem, OR
Position in REGN
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$362,900
-$75,186 QoQ
Shares Held
582
+2.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#887
of 1,322 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Keudell/Morrison Wealth Management holds $2,313,445 across 6 Biotechnology names. REGN ranks #3 (15.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KYMR |
Kymera Therapeutics, Inc.
|
5,215 | $598,004 | |
| 2 | ARGX |
Argenx SE
|
506 | $469,451 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
582 | $362,900 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,359 | $327,478 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
612 | $303,998 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
|
6,450 | $251,614 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $362,900 | 582 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $438,086 | 567 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $458,490 | 594 | Shares | Sole | 2026-02-06 | |
| 2025-06-30 | $364,875 | 695 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $371,024 | 585 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $391,069 | 549 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $403,676 | 384 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $403,595 | 384 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $369,596 | 384 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $337,263 | 384 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $316,016 | 384 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $275,919 | 384 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $315,521 | 384 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $277,052 | 384 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $264,526 | 384 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $244,727 | 414 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $325,463 | 466 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $298,077 | 472 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $355,240 | 587 | Shares | Sole | 2021-12-08 | |
| 2021-06-30 | $349,646 | 626 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $296,185 | 626 | Shares | Sole | 2021-04-13 | |
| 2020-12-31 | $514,029 | 1,064 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $598,404 | 1,069 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $681,025 | 1,092 | Shares | Sole | 2020-07-14 | |
| 2020-03-31 | $533,212 | 1,092 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||